Companies: 10,795·Total market cap: $144.5T
enGene Holdings Inc.

enGene Holdings Inc.

ENGNNASDAQHealthcare● Active
$1.64
$-0.08(-4.65%)
Market Cap$83959762
P/E Ratio—
52W High$12.25
52W Low$1.4
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

enGene Holdings Inc. (ENGN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001980845 · ENGN · NASDAQ · as of Jun 8, 2026

Filing snapshot

241
Total Filings
SCHEDULE 13G/A
Latest Form
2026-05-15
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001980845 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-19
Fiscal Year End
Feb 19, 2026
Accession No.
0001193125-26-059409
Primary Document
engn-20251031.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001980845 · Accession 0001193125-26-059409

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
8-K
2026-05-07Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-13
View
ARSARS
ARS
2026-05-08
View
DEF 14AProxy Statement
DEF 14A
2026-05-08
View
8-KCurrent Report
8-K
2026-05-07
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-05
View
8-KCurrent Report
8-K
2026-04-09
View
S-8Employee Stock Plan Registration
S-8
2026-03-09
View
424B5424B5
424B5
2026-03-09
View
8-KCurrent Report
8-K
2026-03-09
View
10-QQuarterly Report
10-Q
2026-03-09
View
8-KCurrent Report
8-K
2026-03-09
View
EFFECTEFFECT
EFFECT
2026-03-02
View
CORRESPCORRESP
CORRESP
2026-02-26
View
Showing 1–15 of 185 filingsForm 4 / 144 hidden· 241 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001980845  |  Exchange: NASDAQ · Healthcare

enGene Holdings Inc. (NASDAQ: ENGN) has submitted 241 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001980845, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is enGene Holdings Inc.'s most comprehensive regulatory disclosure. The most recent enGene Holdings Inc. 10-K was filed on 2026-02-19 for fiscal year ending 2026. Historical ENGN 10-K annual reports are available from 2023 through 2026.

Investors researching enGene Holdings Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ANRO SEC Filings →ANNX SEC Filings →DBVT SEC Filings →CLLS SEC Filings →SLN SEC Filings →AMRN SEC Filings →LRMR SEC Filings →ALT SEC Filings →
→ ENGN Financials→ ENGN Earnings→ ENGN Insider Trades

Frequently Asked Questions

ENGN SEC Filings · 8 questions

enGene Holdings Inc. (ENGN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 241 filings and access original documents at no cost. enGene Holdings Inc.'s CIK is 0001980845.

ENGN SEC filingsenGene Holdings Inc. SEC documentsfind ENGN 10-K